Regulatory News:
ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced that Pierre-Olivier Goineau will be leaving the company to pursue other interests.
Help employers find you! Check out all the jobs and post your resume.
